Access program - sildenafil citrate, viagra, revatio (DrugBank: Sildenafil)
17 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
6 | パーキンソン病 | 0 |
46 | 悪性関節リウマチ | 0 |
50 | 皮膚筋炎/多発性筋炎 | 0 |
51 | 全身性強皮症 | 0 |
85 | 特発性間質性肺炎 | 0 |
86 | 肺動脈性肺高血圧症 | 1 |
90 | 網膜色素変性症 | 0 |
113 | 筋ジストロフィー | 0 |
210 | 単心室症 | 0 |
211 | 左心低形成症候群 | 0 |
212 | 三尖弁閉鎖症 | 0 |
225 | 先天性腎性尿崩症 | 0 |
226 | 間質性膀胱炎(ハンナ型) | 0 |
278 | 巨大リンパ管奇形(頚部顔面病変) | 0 |
294 | 先天性横隔膜ヘルニア | 0 |
299 | 嚢胞性線維症 | 0 |
301 | 黄斑ジストロフィー | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01582438 (ClinicalTrials.gov) | November 2012 | 19/4/2012 | An Open Label Access Study For Subjects Who Completed A1481156 | A Local, Multicentre, Open Label Access Study, To Provide Sildenafil Therapy For Subjects Who Completed A1481156 Study And Are Judged By The Investigator To Derive Clinical Benefit From Continued Treatment With Sildenafil For Subjects In India | Pulmonary Arterial Hypertension | Drug: Access program - sildenafil citrate, Viagra, Revatio | Pfizer | NULL | No longer available | 12 Years | 30 Years | All | N/A | India |